Mateon Enters into Merger Agreement with PointR Data to Leverage Disruptive AI Technology in Its Innovation-Driven Quest for a Cure of Cancer

Stock Information for Mateon Therapeutics Inc.

Loading

Please wait while we load your information from QuoteMedia.